Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 1 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Keratosis, Actinic 4Skin Neoplasms 3Carcinoma, Squamous Cell 2Breast Neoplasms 2Radiodermatitis 1Head and Neck Neoplasms 1Carcinoma, Intraductal, Noninfiltrating 1

Interventions

Cyclophosphamide 361Trastuzumab 352Paclitaxel 304Docetaxel 272Letrozole 221Capecitabine 221Carboplatin 185Doxorubicin 181Tamoxifen 157Radiotherapy 154Epirubicin 145Fulvestrant 143Anastrozole 139Surveys and Questionnaires 132Exercise 128pertuzumab 113Vinorelbine 110Blood Specimen Collection 109exemestane 106palbociclib 104Bevacizumab 104pembrolizumab 98Magnetic Resonance Spectroscopy 97Albumin-Bound Paclitaxel 87Gemcitabine 84Drug Therapy 83Lapatinib 78130-nm albumin-bound paclitaxel 72Neoadjuvant Therapy 71Cisplatin 69

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
OTHER × Breast Neoplasms × Petrolatum × Clear all
NCT03596073 2025-05-07

Topical Calcipotriene Treatment for Breast Cancer Immunoprevention

Massachusetts General Hospital

Phase 1 Terminated
43 enrolled
Breast

Breast Neoplasms

NCT05073172 2024-05-06

StrataXRT for the Prevention and Treatment of Radiation Dermatitis in Breast Cancer or Head and Neck Cancer Patients

OHSU Knight Cancer Institute

Phase NA Withdrawn
Breast

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡